Company Encyclopedia
View More
name
Bath & Body Works
BBWI.US
Bath & Body Works, Inc. operates as a specialty retailer of home fragrance, personal and body care, soaps, and sanitizer products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions, and body creams. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
129.63 B
BBWI.USMarket value -Rank by Market Cap -/-

Financial Score

22/12/2025 Update
C
Other Specialty RetailIndustry
Industry Ranking15/37
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-41.83%E
    • Profit Margin9.51%B
    • Gross Margin41.28%B
  • Growth ScoreC
    • Revenue YoY-1.05%D
    • Net Profit YoY-24.35%D
    • Total Assets YoY0.10%C
    • Net Assets YoY8.92%B
  • Cash ScoreC
    • Cash Flow Margin1052.07%B
    • OCF YoY-1.05%D
  • Operating ScoreA
    • Turnover1.47A
  • Debt ScoreE
    • Gearing Ratio131.91%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Bath & Body Works (BBWI) valuation: assessing the stock after ongoing same-store sales weakness and declining EPS trends

    Bath & Body Works (BBWI) faces ongoing challenges with weak same-store sales and a projected 5% revenue drop, leading to a year-to-date share price decline of 47.8%. Despite trading at a steep discount, the stock's valuation is debated, with some seeing it as undervalued at $40.73. Key risks include lingering debt from the Victoria’s Secret split and slower international expansion. Investors are advised to consider both the potential rewards and risks.

    Simplywall·
    US
    BBWI
    +0.87%
    Simplywall·
    US
    BBWI
    +0.87%

    Bath & Body Works (BBWI) Gets a Hold from Argus Research

    Argus Research's Taylor Conrad maintained a Hold rating on Bath & Body Works, with shares closing at $19.64. Conrad, a 3-star analyst, has a 7.1% average return. Guggenheim's Simeon Siegel also rated it Hold, while Wells Fargo maintained a Buy rating. Conrad covers the Consumer Defensive sector, including stocks like Church & Dwight and Clorox.

    Tip Ranks·
    US
    BBWI
    +0.87%
    Tip Ranks·
    US
    BBWI
    +0.87%

    Bath & Body Works: Undervalued Retail Leader With Strong FCF

    Bath & Body Works (BBWI) is highlighted as an undervalued stock with strong free cash flow and a robust direct-to-consumer model. Despite retail challenges, BBWI maintains high margins and aggressive buybacks, shrinking share count. With an IV/P of 1.40, indicating intrinsic value 40% above market price, and an Acquirer’s Multiple of 7.20, BBWI is seen as a compelling opportunity for value investors. The company prioritizes buybacks over dividends, enhancing per-share value. BBWI's stable revenue and pricing power suggest mispricing due to market pessimism.

    Talkmarkets·
    US
    BBWI
    +0.87%
    Talkmarkets·
    US
    BBWI
    +0.87%

    Bath & Body Works (BBWI): Valuation Check After Earnings Miss, Lower Guidance and Insider Buying

    Bath & Body Works (BBWI) experienced a challenging quarter with missed earnings and lowered guidance, leading to a significant stock decline. The stock is currently trading at $19.94, with a year-to-date return of -47%. Analysts suggest the stock is undervalued, estimating a fair value of $40.73. The company's valuation is complicated by its 2021 spin-off from L Brands. Investors are advised to consider potential risks, including debt reduction and growth challenges, while exploring other investment opportunities.

    Simplywall·
    US
    BBWI
    +0.87%
    Simplywall·
    US
    BBWI
    +0.87%

    Bath & Body Works stock tanked after earnings. Directors bought up shares.

    Shares of Bath & Body Works plunged 25% after third-quarter earnings, the worst drop since 2020.

    MSN·
    US
    BBWI
    +0.87%
    MSN·
    US
    BBWI
    +0.87%
    © 2025 Longbridge｜Disclaimer